Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Copyright policy )Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Messenger RNA-based vaccines against COVID-19 induce a robust anti-SARS-CoV-2 antibody response with potent viral neutralization activity. Antibody effector functions are determined by their constant region subclasses and by their glycosylation patterns, but their role in vaccine efficacy is unclear. Moreover, whether vaccination induces antibodies similar to those in patients with COVID-19 remains unknown. We analyze BNT162b2 vaccine-induced IgG subclass distribution and Fc glycosylation patterns and their potential to drive effector function via Fcγ receptors and complement pathways. We identify unique and dynamic pro-inflammatory Fc compositions that are distinct from those in patients with COVID-19 and convalescents. Vaccine-induced anti-Spike IgG is characterized by distinct Fab- and Fc-mediated functions between different age groups and in comparison to antibodies generated during natural viral infection. These data highlight the heterogeneity of Fc responses to SARS-CoV-2 infection and vaccination and suggest that they support long-lasting protection differently.
- Sheba Medical Center Israel
- United States Public Health Service United States
- Schneider Children's Medical Center Israel
- Tel Aviv Sourasky Medical Center Israel
- Austin Health & Human Services Department United States
Adult, Male, COVID-19 Vaccines, Glycosylation, QH301-705.5, Vaccine Efficacy, Antibodies, Viral, Article, antibodies, Humans, Biology (General), Israel, Fc-Glycosylation, BNT162 Vaccine, IgG-Fc, Aged, Vaccines, Synthetic, BNT162b2 mRNA vaccine, Fcγ receptors, SARS-CoV-2, Vaccination, COVID-19, Middle Aged, Immunoglobulin G, Spike Glycoprotein, Coronavirus, Female, mRNA Vaccines
Adult, Male, COVID-19 Vaccines, Glycosylation, QH301-705.5, Vaccine Efficacy, Antibodies, Viral, Article, antibodies, Humans, Biology (General), Israel, Fc-Glycosylation, BNT162 Vaccine, IgG-Fc, Aged, Vaccines, Synthetic, BNT162b2 mRNA vaccine, Fcγ receptors, SARS-CoV-2, Vaccination, COVID-19, Middle Aged, Immunoglobulin G, Spike Glycoprotein, Coronavirus, Female, mRNA Vaccines
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).54 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!